推荐产品
儲存期限
limited shelf life, expiry date on the label
製造商／商標名
Paragon Scientific Ltd
黏度
990.0 mPa.s(25 °C)
應用
cleaning products
cosmetics
flavors and fragrances
food and beverages
personal care
形式
mixture
正在寻找类似产品? 访问 产品对比指南
一般說明
Find detailed technical data for all Paragon General Viscosity Standards on the Paragon Scientific webpage
Please note that the value stated on this page is nominal. All certified values for the current lots of all Paragon General Viscosity Standards can be found on the Paragon Scientific webpage
This product is a certified reference material (CRM) certified to International Standards BS EN ISO / IEC 17025 and ISO 17034 under UKAS accreditation.
訊號詞
Danger
危險聲明
危險分類
Asp. Tox. 1 - Skin Irrit. 2
儲存類別代碼
10 - Combustible liquids
水污染物質分類（WGK）
WGK 1
閃點（°F）
Not applicable
閃點（°C）
Not applicable
从最新的版本中选择一种：
分析证书(COA)
Lot/Batch Number
其他客户在看
B R Achyut et al.
PLoS genetics, 9(2), e1003251-e1003251 (2013-02-15)
Deletion of tumor suppressor genes in stromal fibroblasts induces epithelial cancer development, suggesting an important role of stroma in epithelial homoeostasis. However, the underlying mechanisms remain to be elucidated. Here we report that deletion of the gene encoding TGFβ receptor
Sumit Pramanik et al.
Scientific reports, 5, 9806-9806 (2015-05-08)
Scaffold design from xenogeneic bone has the potential for tissue engineering (TE). However, major difficulties impede this potential, such as the wide range of properties in natural bone. In this study, sintered cortical bones from different parts of a bovine-femur
Marta López-García et al.
Food chemistry, 199, 597-604 (2016-01-19)
In this work MALDI-TOF mass spectroscopy was investigated to characterise the β-glucan profiles of several commercial health supplements, without any derivatisation or purification pre-treatment. The effect of two solvents (water and dimethyl sulfoxide) and two MALDI matrices (2,5-dihydroxybenzoic acid and
Nicolas Floc'h et al.
Molecular cancer therapeutics, 17(5), 885-896 (2018-02-28)
EGFR exon 20 insertions (Ex20Ins) account for 4% to 10% of EGFR activating mutations in non-small cell lung cancer (NSCLC). EGFR Ex20Ins tumors are generally unresponsive to first- and second-generation EGFR inhibitors, and current standard of care for NSCLC patients
Yumiao Zhang et al.
Nature communications, 7, 11649-11649 (2016-05-20)
Injectable hydrophobic drugs are typically dissolved in surfactants and non-aqueous solvents which can induce negative side-effects. Alternatives like 'top-down' fine milling of excipient-free injectable drug suspensions are not yet clinically viable and 'bottom-up' self-assembled delivery systems usually substitute one solubilizing
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门